News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗4 briefsClear filters
News
AI drug company Iambic Therapeutics completes USD 150 million IPO at USD 16 per share
AI drug company Iambic Therapeutics completed a USD 150 million IPO at USD 16 per share, listing on the US stock market.
Oct 15, 2026Read brief →
News
Iambic Therapeutics Acquired
On 2026-2-9, according to Xiniu Data, Iambic Therapeutics was acquired for USD 1.7 billion. Investors were Takeda Pharmaceutical Co.
Feb 9, 2026Read brief →
News
Iambic Therapeutics raises USD 100 million in equity financing
Brief not available.
Nov 10, 2025Read brief →
News
Iambic Therapeutics raises USD 50 million in Series B financing
Brief not available.
Jun 24, 2024Read brief →